We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
1901
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.26M | ﹤0.01% |
44,092
+14,311
| +48% | +$455K |
|
1902
Travere Therapeutics
TVTX
$5.89B
| $1.25M | ﹤0.01% |
55,247
+18,748
| +51% | +$466K |
|
1903
Enterprise Financial Services Corp
EFSC
$2.4B
| $1.24M | ﹤0.01% |
33,050
+9,726
| +42% | +$433K |
|
|
PEI
1904
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $1.24M | ﹤0.01% |
13,915
+2,110
| +18% | +$263K |
|
1905
Tredegar Corp
TG
$270M
| $1.24M | ﹤0.01% |
77,904
+12,698
| +19% | +$227K |
|
1906
BGC Group
BGC
$4.97B
| $1.23M | ﹤0.01% |
238,189
-127,936
| -35% | -$843K |
|
|
BKS
1907
DELISTED
Barnes & Noble
BKS
| $1.23M | ﹤0.01% |
173,631
+29,529
| +20% | +$197K |
|
|
COOP
1908
DELISTED
Mr. Cooper
COOP
| $1.23M | ﹤0.01% |
105,154
+74,083
| +238% | +$1.06M |
|
|
CBPX
1909
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $1.23M | ﹤0.01% |
48,165
+14,976
| +45% | +$438K |
|
|
TERP
1910
DELISTED
TerraForm Power, Inc
TERP
| $1.22M | ﹤0.01% |
108,636
+31,774
| +41% | +$357K |
|
1911
AppFolio
APPF
$6.87B
| $1.22M | ﹤0.01% |
20,519
+7,040
| +52% | +$427K |
|
1912
Floor & Decor
FND
$6.39B
| $1.21M | ﹤0.01% |
46,833
-492
| -1% | -$14.4K |
|
1913
BioCryst Pharmaceuticals
BCRX
$2.36B
| $1.21M | ﹤0.01% |
149,874
+55,789
| +59% | +$434K |
|
1914
Par Pacific Holdings
PARR
$3.46B
| $1.21M | ﹤0.01% |
84,998
+15,464
| +22% | +$264K |
|
1915
Future Fuel
FF
$229M
| $1.2M | ﹤0.01% |
75,926
+14,156
| +23% | +$236K |
|
1916
Iovance Biotherapeutics
IOVA
$2.77B
| $1.2M | ﹤0.01% |
136,088
+64,879
| +91% | +$626K |
|
1917
Clearwater Paper
CLW
$369M
| $1.2M | ﹤0.01% |
49,074
+8,580
| +21% | +$231K |
|
|
HAPN
1918
Happen Inc
HAPN
$2.27B
| $1.19M | ﹤0.01% |
90,684
+27,765
| +44% | +$458K |
|
|
GLUU
1919
DELISTED
Glu Mobile Inc.
GLUU
| $1.19M | ﹤0.01% |
147,652
+48,227
| +49% | +$343K |
|
1920
Harmonic Inc
HLIT
$1.27B
| $1.19M | ﹤0.01% |
252,308
+42,434
| +20% | +$232K |
|
1921
Advanced Drainage Systems
WMS
$11.4B
| $1.19M | ﹤0.01% |
49,132
+16,225
| +49% | +$436K |
|
|
CTWS
1922
DELISTED
Connecticut Water Service Inc
CTWS
| $1.19M | ﹤0.01% |
17,818
+5,733
| +47% | +$395K |
|
1923
Sonic Automotive
SAH
$2.68B
| $1.19M | ﹤0.01% |
86,454
+11,191
| +15% | +$186K |
|
|
MCRN
1924
DELISTED
Milacron Holdings Corp.
MCRN
| $1.19M | ﹤0.01% |
99,949
+32,211
| +48% | +$484K |
|
1925
Atlanta Braves Holdings Series B
BATRK
$3.13B
| $1.19M | ﹤0.01% |
47,601
+15,267
| +47% | +$386K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.